Vidutolimod (CMP-001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vidutolimod (CMP-001), covering 2024-10-21 to 2024-10-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination with Nivolumab Vs. Nivolumab [Phase 2]